middle.news
Noxopharm Launches HERACLES Trial, Expands Sofra Collaborations Amid Funding Push
8:46am on Wednesday 30th of July, 2025 AEST
•
Biotechnology
Read Story
Noxopharm Launches HERACLES Trial, Expands Sofra Collaborations Amid Funding Push
8:46am on Wednesday 30th of July, 2025 AEST
Key Points
HERACLES clinical trial for SOF-SKN commenced after ethics approval
Expanded collaborations with multiple biotech firms validating Sofra technology
Positive data from BioRay Pharmaceutical strengthens platform credibility
Cash reserves at A$1.55 million with net operating outflows of A$2.45 million
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NOX
OPEN ARTICLE